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ABSTRACT
Purpose: To study the role of pentoxifylline (PTX) on remote kidney injury caused by muscle ischemia of left hindlimb
of rats. Methods: After xylazine and ketamine anesthesia, the left hindlimb of rats (n=66) were submitted to 6 hours
ischemia (clamping the left common iliac artery). Three groups were used: sham group (SG, n=6), early group (EG, n=30)
with reperfusion after 4 hours and late group (LG, n=30) with reperfusion after 24 hours. The saline solution (EG1, n=10
and LG1, n=10) or PTX (40mg.Kg-1) was administered in the reperfusion beginning (EG2, n=10/LG2, n=10) or divided in
two doses in the ischemia beginning and reperfusion beginning (EG3, n=10/LG3, n=10). The plasmatic creatinokinase,
urea, creatinine, sodium and potassium values were measure and histological samples from left kidney were prepared
and H&E stained for scored cellular necrosis and degeneration of kidney tubules and thickness glomerulus
determination. The apoptosis index was determined by immunohistochemical expression of the caspase-3. The tests of
Mann-Whitney and Kruskal-Wallis (p < 0.05) were applied. Results: The urea (90.5 ± 30.96 mg.dL-1), creatinine (2.28 ±
0.54 mg.dL-1), potassium (16 ± 3.66 mmol.dL-1) and mesangium thickness (0.97 ± 0.42 µm) values were significantly
higher in group LG3. There was no significantly difference of caspase 3 expression between EG2 (16.35 ± 1.65%) and
LG3 (15.57 ± 2.54%), and both were significantly worse than SG (9.8 ± 1.98%). Conclusions: The PTX has some
protecting effect on remote kidney injury due to hindlimb ischemia/reperfusion injury only in the early phase of
reperfusion.
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RESUMO
Objetivo: Estudar o papel da pentoxifilina (PTX) nas lesões à distância no rim causadas pela isquemia no membro posterior
esquerdo de ratos. Métodos: Sob anestesia com xilazina e quetamina, o membro posterior de ratos (n=66) foi submetido a
6 horas de isquemia pelo clampeamento da artéria ilíaca comum esquerda. Foram estudados três grupos: grupo simulado
(SG, n=6), grupo precoce (EG, n=30) após quatro horas de reperfusão e grupo tardio (LG, n=30) após 24 de reperfusão. A
solução salina (EG1, n=10 e LG1, n=10) ou a PTX (40mg.Kg-1)  foram administradas no início da reperfusão(EG2, n=10/LG2,
n=10)  ou divididas em duas aplicações no início da isquemia e no início da reperfusão (EG3, n=10/LG3, n=10). Foram
medidos os valores plasmáticos da creatinofosfoquinase, uréia, creatinina, sódio e potássio. Amostras do rim esquerdo
foram preparadas e coradas em HE para realizar o escore de necrose de células tubulares renais ou presença de obstrução
tubular renal na área do córtex renal e da presença do espessamento do mesângio glomerular. O índice de apoptose foi
determinado pela expressão imunoistoquímica da caspase-3. Foram aplicados os testes de Mann-Whitney e Kruskal-
Wallis (p <  0.05). Resultados: a dosagem de uréia (90,5 ± 30,96 mg.dL-1), creatinina (2,28 ± 0,54 mg.dL-1), potássio (16 ± 3,66
mmol.dL-1) e a espessura do mesângio(0,97 ± 0,42 µm) foram significantemente maiores nos animais do grupo LG3. Não
houve diferença significante na expressão da caspase-3 entre os grupos EG2 (16,35 ± 1,65%) e LG3 (15,57 ± 2,54%) e ambos
foram significantemente piores que o grupo SG (9,8 ± 1,98%). Conclusão: A PTX oferece algum efeito protetor nas lesões
à distância nos rins de animais submetidos à lesão de isquemia e reperfusão de membro posterior, no período de até quatro
horas após a reperfusão.
Descritores: Isquemia. Músculo Esquelético. Rim. Pentoxifilina. Caspase 3. Ratos.
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Introduction
Reperfusion of the acutely ischemic limb may,
paradoxically, lead to systemic complications that account
for significant morbidity and mortality1. Skeletal muscle
ischemia-reperfusion is associated with a systemic
inflammatory response and determines the effect on remote
organs (lung, liver, and kidney) structure and function1,2. It
is well known that interactions between the blood elements
and the vascular endothelium are responsible for the
reperfusion injury: endothelial injury with swelling and lysis
due to loss of ionic and osmotic gradients, loss of
vasoregulatory control, diminished of the endothelium-
derived vasodilator nitric oxide, polymorph nuclear
leukocytes (PMN) activation and subsequent release of lytic
enzymes leading to tissue damage1,2.
The development of remote organ dysfunction
was observed only following reperfusion, which implies that
humoral and/or cellular mediators produced locally in the
limb were responsible for mediating remote organ injury3,4.
The failure to identify histological evidence of injury in the
kidney may indicate that injury in this organ was not severe
enough to cause structural damage. Since functional
derangement normally precedes evidence of structural
organ injury, the experimental ischemia period must be long
enough to allow for the structural changes to develop.
Although histological evidence of injury was demonstrated
only in the lung, the biochemical evidence of simultaneous
hepatic and renal dysfunction indicates that multiple organ
dysfunctions following hindlimb ischemia reperfusion occur
as a central systemic event rather than sequential failure of
individual organs4,5,6.
Multiple pharmacological agents could potentially
limit reperfusion injury, including substances that target
free radicals, limit initiation of the inflammatory response,
or serve as substrate for compounds that preserve
endothelial function7. Pentoxifylline (PTX) is a
methylxanthine derivative with multiple hemorheologic
properties. PTX through effects of increasing intracellular
cyclic AMP on red blood cells improve the oxygen delivery
to ischemic tissues and also increases the AMP cyclic on
PMN and decreased oxygen free radical production7-11. In
addition, PTX limited the inflammatory response with
reduction in cellular activation, phagocytosis and
endothelium adhesion. There are evidences that PTX also
reduces the nitric oxide destruction10.
The purpose of this study was to determine
whether hindlimb ischemia-reperfusion is associated with
the effect on remote organ structure and function, like the
kidney, in a rat model and, secondly, to determine the role of
PTX modulation on this remote kidney damage.
Methods
The experimental protocol was approved by the
Ethics Committee of the Federal University of São Paulo –
Escola Paulista de Medicina (UNIFESP – EPM), São Paulo,
Brazil, ratified and developed at Federal University of Mato
Grosso do Sul (UFMS), Campo Grande, MS, Brazil. All the
procedures followed, rigorously, the existent regulations
about animal experimentation.
Sixty-six male Wistar rats, four months aged,
weighing between 300-350g were acclimated to laboratory
conditions for 7 days and fed a standard rat chow and water
ad libitum. All the surgical procedures and ischemia periods
were done under general anesthesia, using intraperitonial
ketamine (50mg.Kg-1), xylazine (20mg.Kg-1) and spontaneous
respiration. All procedures were done in a heating
environment. The analgesic nalbuphine hydrochloride
(NubainTM) was used in a subcutaneous via (2mg.Kg-1)
during four or twenty-four observation time.
At first, all animals were submitted to laparotomy
with exposure of the infrarenal abdominal aorta and the
bilateral iliac arteries. The complete ischemia was induced
by a vascular clamping of the left common iliac artery. The
ischemia was verified by the absence of distal arteries pulses
and by absence of Doppler signals (Medison- Sonoace
9900™ – Linear transductor 5-12MHz).  After six hours of
ischemia the clamp was removed, and reperfusion was
documented by return of Doppler signals in the distal
arteries. The abdominal wound was closed by total
continuous nylon 4.0 suture and the animals return to the
heating cages for four or twenty-four hours of reperfusion
time observation. The 3mL of PTX (TrentalTM - Sanofi
Aventis) dose (40mg.Kg-1) was administered by
intraperitoneal via.
The artery clamping was avoid in the animals of
sham group (SG - n=6) and three were sacrificed at four and
another three at twenty-four hours of reperfusion.  The
animals of reperfusion of four hours (early phase) (EG -
n=30) and twenty four hours (late phase) (LG- n=30) were
divided in group with no PTX (EG1-n=10 and LG1-n=10),
group with PTX immediately before the reperfusion time
(EG2–n=10 and LG2-n=10) and group with PTX immediately
after the ischemia and immediately before the reperfusion
time (EG3-n=10) and LG3-n=10).
At end of reperfusion time the surgical wound was
reopened and the left nefrectomy was performed and a
venous blood was colleted from left cardiac camera. The
animals were euthanized by high-dose of anesthetics until
cardiac arrest.
The blood samples were analyzed by Automatic
DADE AnalyzerTM (Behring Dimension AR) to determine
the biochemical plasmatic measures of creatinokinase (CK),
urea, creatinine, sodium and potassium.
Samples of the left kidney was immersed in a volume
of 10% formalin solution ten times over the kidney volume,
embedded in paraffin wax and 4µm sections were cut and
stained with hematoxilin and eosin. Histological evaluation
was undertaken by an independent pathologist who had
no knowledge of the experimental groups from which the
specimens were derived. The macroscopic assessment was
performed using the follow grading scoring: 0 (no changes),
1 (mild), 2 (moderate) and 3 (severe). The abnormalities
detected in 20 random sites in every animal plate were
subjectively scored and compared with the controls. The
evaluated parameters were mesangio thickness, renal
tubules degeneration and necrosis. The tissue injury was
evaluated by the sum of parameters (minimum = 0 to
maximum = 21). The sections were carefully examined
microscopically and the best observed areas were selected
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for morphometric studies. The images were captured in a
high-resolution Samsung® camera coupled to a light Nikon
E200® microscope by the AxioVision-Rel® software (Zeiss).
In 20 selected sites the mesangio thickness was measured
(µm) from the ratio of glomerulus and the Bowman capsule.
Immunohistochemistry for caspase-3 (rabbit polyclonal
antibody - Sigma Chemical Corporation, P- 7886, Saint Louis
MO. USA - Cuello, A.C., Immunohistochemistry II, Wiley
Press, NY - 1993) was performed using a combination avitin-
biotin-peroxidase method and microwave antigen retrieval
on formalin-fixed paraffin-embedded tissues. After
deparaffinization, sections were treated with 10% hydrogen
peroxidase in filtered water to block endogenous peroxidase
activity. To retrieve the antigen, slides were boiled with10
mmol/l citrate buffer (pH 6.8) for 10min. After pre incubation
with for 20 min, sections were incubated with the primary
antibody for 1h at room temperature, followed sequentially
by biotinylated goat 1:300 (Vector Corporation, Burlingame,
California, USA). We used Harris’ hematoxylin, as the
chromagen, and hematoxylin for nuclear counterstain. The
slides were evaluated in a blinded fashion by the same
investigator. The images were captured through a high
resolution camera by the Imagelab software® and the
analysis was conducted in a Nikon E200® optic microscope.
The software used was the Imagelab® that calculated the
ratio of brown color tissue/no brown color tissue. Apoptotic
cells in the renal cortex were counted in ten slices of ten
separate regions.
Statistics were performed on SPSS software
(SPSS™ Inc. Chicago, IL, USA). The significance of the
differences in histological scores and in thiness
measurements were made by Mann Whitney and the
Kruskall Wallis. A P value<0.05 was considered to be
statistically significant.
Results
The comparison of CK (values in U.L-1) from the
sham group (751.00±130.79) with the group EG1
(3332.30±1384.39) and LG1 (2215.00±1823.14) shown that
the ischemia led to damage of skeletal muscle, but the PTX
do not protected the muscle after the reperfusion (Figure
1). In fact, it was evident on early phase with PTX only in
the ischemia EG2 (3143.60±1604.57) or both ischemia and
reperfusion time
 EG3 (2010.70±705.43) and in the late phase LG2
(2074.10±1004.32) or LG3 (2451.20±1831.87).
There was no significant increase of plasmatic urea
values in the comparison of sham group (53.23± 4.68) with
EG1 (65.30±22.25) and LG1 (58.56±13.23). In the early phase
the PTX do not diminished the plasmatic urea level in EG2
(68.40±20.19) and EG3 (57.10±9.34) groups. In the late phase
LG2 (62.30±19.72) and LG3 (90.50±30.96) the urea plasmatic
level was significantly greater than the sham and the LG1.
The fact can mean that PTX do not protected the renal
function and instead probably impaired them.
The same profile occurred with the plasmatic
values of creatinina.  There was no significant increase of
urea values in the comparison of sham group (0.73± 0.14)
with EG1 (0.96±0.42) and LG1 (1.22±0.25). In the early
phase the PTX do not diminished the plasmatic creatinine
level in EG2 (1.06±.0.19) and EG3 (0.79±0.09) groups. In
the late phase LG2 (0.97±0.43) and LG3 (2.28±0.54) the
creatinine plasmatic level was significantly greater than
the sham and the LG1 (Figure2)
CK plasmatic concentration (mean ±sd) in
sham group (SG), I/R 4 hours group (EG) and
I/R 24 hours group (LG) without PTX (1), with
PTX at initial ischemia time (2) and PTX at
initial of ischemia and initial reperfusion time
(3). Values in U.L-1 (mean ±sd)
FIGURE 2 - Urea and creatinine plasmatic concentration (mean ±sd) in sham group (SG), I/R 4 hours group (EG) and I/R 24 hours
group (LG), without PTX (1), with PTX at initial ischemia time (2) and PTX at initial of ischemia and initial reperfusion time (3).
Values in mmol.dl-1 (mean ±sd)
 FIGURE 1 -
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The plasmatic concentration of sodium on the EG1
(151.60±7.00) was significantly greater than the sham group
(141.17± 2.23). The PTX administration does not had any
influence and the level of plasmatic sodium concentration
kept high on EG2 (147.60±5.90) and EG3 (150.00±4.20). In
the late phase the sodium concentration of LG2 (155.20±6.60)
and LG3 (160.00±3.23) was significantly greater than those
of sham group early phase groups.
The similar profile occurred with the plasmatic values of
potassium. The plasmatic concentration of potassium on
the EG1 (10.1±2.05) was significantly greater than the sham
group (5.08± 0.66). The PTX administration does not had
any influence and the level of plasmatic potassium
concentration kept high on EG2 (12.2±3.38) and EG3
(6.0±0.77). In the late phase the potassium concentration of
 LG2 (10.3±5.12) and LG3 (16.0±3.66) was significantly higher
than those of sham group early phase groups (Figure 3).
 The enlargement of glomerulus area occurred meanly by
liquid sequestration (edema) and there was no significantly
differences with the EG1 (0.74±0.07) and EG2 (0.64± 0.21),
but occurred a significantly difference with the EG3
(0.88±0.07). The edema become more evident in the late
phase in the groups LG1 (0.59±0.07), LG2 (0.85±0.33) and
LG3 (0.97±0.42).
The deposit of amorphous substances or necrotic cells on
the kidney tubules and morphological evidences of cell
necrosis was significantly higher in EG2 (1.15± 0.07) and
EG3 (1.20±0.21) in comparison with EG1 (0.84± 0.14). In the
late phase there was no significant differences among LG1
(1.03±0.49), LG2 (0.70±0.14) and LG3 (0.87±0.07) (Figure 4).
FIGURE 3 - Sodium and potassium plasmatic concentration (mean ±sd) in sham group (SG), I/R 4 hours group (EG)
                   and I/R 24 hours group (LG), without PTX (1), with PTX at initial ischemia time (2) and PTX at initial of
                      ischemia and initial reperfusion time (3). Values in mmol.dl-1 (mean ±sd)
FIGURE 4 - Mesangio thickness [µm2 (mean ±sd)] and percentage of damaged renal tubules (mean ±sd) in sham group
                        (SG), I/R 4 hours group (EG) and I/R 24 hours group (LG),  without PTX (1), with PTX at initial ischemia time
                      (2) and PTX at initial of ischemia and initial reperfusion time (3)
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A significantly differences occurred in the apoptosis
expressed by caspase-3 in the groups EG1 (11.86± 2.40),
EG2 (14.16± 4.55) and EG3 (10.38± 1.54) in comparison with
SG (9.8± 1.98). The PTX increased the caspase-3 expression
in the late phase too, as shown by the results in LG1 (14.19±
3.72), LG2 (16.35±1.65), and LG3 (15.57±2.54) (Figure 5).
FIGURE 5 - Caspase-3 expression (mean ±sd) in sham group
(SG), I/R 4 hours group (EG) and I/R 24 hours group (LG),
without PTX (1), with PTX at initial ischemia time (2) and
PTX at initial of ischemia and initial reperfusion time (3)
Discussion
Morbidity and mortality following reperfusion of
the acutely ischemic limb may be a manifestation of multiple
organ dysfunction caused by a systemic inflammatory
response triggered by reperfusion of the ischemic
extremities.
The findings in this study indicate that reperfusion
of the ischemic limb leads, within four or twenty-four hours
of reperfusion, to a systemic response as demonstrated by
the functional and morphological impairment of the kidney.
Magdi et al2 related that the restoration of blood
flow to an acutely ischemic lower limb in rats may,
paradoxically, result in systemic complications and
unexpected mortality. There was a significant increase in
plasma concentrations of urea, creatinine, aspartate
transaminase, alanine transaminase, and lactic
dehydrogenase in reperfused animals compared with
controls. Plasma concentrations of tumor necrosis factor-
alpha (TNF-a) and interleukin-6 increased progressively and
significantly in animals subjected to bilateral hind limb
ischemia followed by 1 hour of reperfusion.
In our experimental model of unilateral hindlimb
ischemia was associated to significant increase of plasmatic
sodium and potassium (Figure 3) at four (p<.0159) or twenty-
four hours (p<0.42) and the mild increase (Figure 2) of urea
(p<0.0399) and creatinine (p<0.0382) shown the function
renal impairment caused by the skeletal muscle I/R injury.
The mesangial enlargement and the tubular cells necrosis
(Graphic 4) were evidences of the remote I/R renal injury.
Gradl et al4 reported that remote organ failure is
attributed to the systemic action of locally released
mediators; it is so far unclear to what extent a direct cell
injury and the consequences of ischemia or a secondary
injury due to locally released mediators contribute to the
manifestation of tissue damage at the primary site of trauma.
Rats that underwent traumatized muscle presented with
apoptotic cell death, as given by in vivo fluorescence
microscopy, caspase-3 protein cleavage. They suggested
that may prompt future efforts in the therapy of ischemia/
reperfusion injury to focus not only on antimediator
strategies, but to add regimens targeting perfusion failure
and tissue apoptosis.
The caspase-3 cleavage expression of our sham
group was significantly lesser than that of group after four
hours of reperfusion [EG1 (0.0378)] or twenty-four hours
[LG1 (0.0398)]. The hindlimb I/R injury led to a remote
increase of apoptosis in renal parenchyma.
Although a diversity of mechanisms exist by which
the kidney can be damaged during muscle ischemia,
inflammatory response and the apoptosis are believed to
be primary contributors to renal insult. In addition, the high
metabolic demands of active tubular reabsorption and the
oxygen diffusion shunt characteristic of renal circulation
make the kidney particularly vulnerable to ischemic injury.
Although numerous pharmacologic interventions to prevent
or treat acute renal injury have shown promise in animal
models no one is safe and effective enough to be used in
large scale12-14.
The beneficial effects of post-insult administration
of PTX were related as an agent experimentally studied in
various ischemic diseases, including in models of renal
impairment due to remote muscle ischemia/reperfusion injury
14-17.
The current range dose of PTX related is from
20mg.Kg-1 to 45mg.Kg-1i.p. using rats or rabbits models. On
the other hand, there were various designs of administration
time. The PTX may be used in chronic or acute essays. In
models of acute I/R injury the administration were often
done in the reperfusion time. Since these events occur in
flowing blood, PTX needs to be present in this milieu to
exert its effects1.
In our model, after four hours of reperfusion (early
group), the PTX (40mg. Kg-1 i.p.) administrated in the
beginning of ischemia do not reduced significantly the
plasmatic level of urea, creatinine, sodium, potassium,
neither the caspase-3 expression. On the other hand, when
PTX was administrated in the beginning of ischemia (half
dose) and beginning of reperfusion (second half dose)
occurred a significantly reduction in the plasmatic levels of
creatinine (p<0.0374) and potassium (p<0.0405) and a mild
tendency of reduction in the sodium (p<0.0523) and urea
(p< 0.0589). Furthermore, the caspase expression showed
significantly decrease when administrated in the beginning
of ischemia and beginning of reperfusion. Our results
reinforced that is thought about the presence of PTX on
blood circulation to lead the better effects.
Teruya R et al
34 - Acta Cirúrgica Brasileira - Vol 23 (1) 2008
Nevertheless, after twenty-four hours of reperfusion
the plasmatic levels of urea, creatinine, sodium and
potassium showed no significantly difference with the
group without PTX and PTX administrated in the beginning
of ischemia. The same profile occurred with the caspase-3
expression. The PTX in the beginning of ischemia and
beginning of reperfusion was associated to a significantly
increase in the plasmatic of creatinine (p<0.0359), while the
urea (p<0.0589), sodium (p<0.0532) and potassium (p<0.567)
showed a discreet increase. The caspase-3 expression
showed no differences with others groups. Our results
implied that PTX was associated to worse results when
used in the late time.  There were no others similar reports in
the biomedical literature and further investigation should
be done to clarify this point.
The edema and tubular necrosis (Figure 4) had the
same profile in the early and late phases with no significantly
differences with the period of PTX administration. The PTX
do not protected the kidney from necrosis and edema due
to the remote muscle I/R injury.
These unexpected results in the late period
probably should be associated to some bias occurred in
the hydro-electrolytic balance, in the divided PTX doses or
on the dose concentration. Another design will be performed
focused in the effects of PTX in the late time reperfusion.
Our data support the favorable role of PTX to
protect the kidney from remote skeletal muscle l/R injury,
when applied in the reperfusion time and until four hours
after reperfusion. The protection after twenty-four hours
should be object of further studies because conflicting
results with the rational use of PTX and the others result
reported in the biomedical revue.
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